Incidence, Predictors, and Outcomes of Acquired Thrombocytopenia After Percutaneous Coronary Intervention: A Pooled, Patient-Level Analysis of the CHAMPION Trials (Cangrelor Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition).

Incidence, Predictors, and Outcomes of Acquired Thrombocytopenia After Percutaneous Coronary Intervention: A Pooled, Patient-Level Analysis of the CHAMPION Trials (Cangrelor Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition). Circ Cardiovasc Interv. 2018 04; 11(4):e005635.

View in: PubMed

subject areas

Adenosine Monophosphate
Aged
Female
Hemorrhage
Humans
Incidence
Male
Middle Aged
Percutaneous Coronary Intervention
Platelet Aggregation Inhibitors
Platelet Count
Randomized Controlled Trials as Topic
Risk Assessment
Risk Factors
Thrombocytopenia
Time Factors
Treatment Outcome

authors with profiles

Robert Harrington